CAS number: 13115-71-4

Taking advantage of Axplora’s backward integration into biles collection and its proprietary enzymatic expertise, Axplora has decided to develop, market or custom develop various bile acid derivatives.
Given our large CDMO expertise, we can easily merge our bile acid knowlege with NCE requirement and support clinial phase I to commercial needs across our 9 large scale manufacturing sites on 3 continents. The combination of high skill, low cost and enzymtic expertise is arguably next to none.
  • Monograph Please contact us if you are looking for such a derivative.